LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of Oczyesa®, octreotide subcutaneous depot (CAM2029),...
Read More Details
Finally We wish PressBee provided you with enough information of ( CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU )
Also on site :
- The Simple Spaghetti Recipe Isabella Rossellini Swears By
- Allison Holker Debuts New Relationship 2 Years After Husband tWitch Boss' Death, Fans Are 'So Thrilled' For Her
- 7 Signs It’s Time to Take Your Memory Issues Seriously